Reply to Correspondence: What Is the Next Step for Patients With Aspirin‐Exacerbated Respiratory Disease: Biologics With or Without Aspirin Therapy?

Inmaculada Doña, Rocío Sáenz de Santa María, Esther María Moreno, Joan Bartra, María José Torres

Open source

DOI
10.1111/all.16520
Published
2025-03-06
Container
Allergy
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/all.16520,
  title = {Reply to Correspondence: What Is the Next Step for Patients With Aspirin‐Exacerbated Respiratory Disease: Biologics With or Without Aspirin Therapy?},
  author = {Inmaculada Doña and Rocío Sáenz de Santa María and Esther María Moreno and Joan Bartra and María José Torres},
  year = {2025},
  journal = {Allergy},
  doi = {10.1111/all.16520},
  url = {https://doi.org/10.1111/all.16520}
}

RIS

TY  - JOUR
TI  - Reply to Correspondence: What Is the Next Step for Patients With Aspirin‐Exacerbated Respiratory Disease: Biologics With or Without Aspirin Therapy?
AU  - Inmaculada Doña
AU  - Rocío Sáenz de Santa María
AU  - Esther María Moreno
AU  - Joan Bartra
AU  - María José Torres
PY  - 2025
JO  - Allergy
DO  - 10.1111/all.16520
UR  - https://doi.org/10.1111/all.16520
ER  - 

APA

Doña, I., María, R. S. D. S., Moreno, E. M., Bartra, J., & Torres, M. J. (2025). Reply to Correspondence: What Is the Next Step for Patients With Aspirin‐Exacerbated Respiratory Disease: Biologics With or Without Aspirin Therapy?. Allergy. https://doi.org/10.1111/all.16520

Source records